Literature DB >> 17687559

Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood-brain barrier breakdown.

Sukriti Nag1, Roopa Venugopalan, Duncan J Stewart.   

Abstract

The significance of caveolin-1, a major constituent of caveolae, and the tight junction proteins occludin and claudin-5 in early blood-brain barrier (BBB) breakdown was assessed by sequential demonstration of the expression of these proteins over a period of 12 h to 6 days post-lesion in the rat cortical cold injury model. Pial and intracerebral vessels of control rats showed punctuate endothelial immunoreactivity for caveolin-1 and caveolin-2, while claudin-5 and occludin were localized as longitudinal strands in endothelium. During the early phase of BBB breakdown following injury at 12 h and on day 2, western blot analyses detected a significant increase in caveolin-1 expression at the lesion site while immunohistochemistry showed that the caveolin-1 increase was localized to the endothelium of lesion vessels. Decreased expression of occludin occurred at the lesion site only on days 2 and 4 post-lesion while claudin-5 expression was decreased only on day 2. Dual labeling for fibronectin, a marker of BBB breakdown, and caveolin-1 or the tight junction proteins demonstrated that only lesion vessels with BBB breakdown showed a marked increase of caveolin-1, loss of occludin and reduced localization of claudin-5. The issue whether these alterations precede or follow BBB breakdown is uncertain; however, increased expression of caveolin-1 preceded the decreased expression of occludin and claudin-5. Thus caveolae and caveolin-1 have an important role in early BBB breakdown and could be potential therapeutic targets in the control of early brain edema.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17687559     DOI: 10.1007/s00401-007-0274-x

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  89 in total

Review 1.  Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Ther Deliv       Date:  2011-08

2.  CRM197-induced blood-brain barrier permeability increase is mediated by upregulation of caveolin-1 protein.

Authors:  Ping Wang; Yunhui Liu; Xiuli Shang; Yixue Xue
Journal:  J Mol Neurosci       Date:  2010-11-16       Impact factor: 3.444

Review 3.  Blood-brain barrier breakdown and neovascularization processes after stroke and traumatic brain injury.

Authors:  Roshini Prakash; S Thomas Carmichael
Journal:  Curr Opin Neurol       Date:  2015-12       Impact factor: 5.710

4.  Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier.

Authors:  Carola Förster; Malgorzata Burek; Ignacio A Romero; Babette Weksler; Pierre-Olivier Couraud; Detlev Drenckhahn
Journal:  J Physiol       Date:  2008-02-07       Impact factor: 5.182

5.  Caveolae-mediated internalization of occludin and claudin-5 during CCL2-induced tight junction remodeling in brain endothelial cells.

Authors:  Svetlana M Stamatovic; Richard F Keep; Michael M Wang; Ivana Jankovic; Anuska V Andjelkovic
Journal:  J Biol Chem       Date:  2009-05-07       Impact factor: 5.157

Review 6.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

7.  Vascular neural network phenotypic transformation after traumatic injury: potential role in long-term sequelae.

Authors:  J Badaut; G J Bix
Journal:  Transl Stroke Res       Date:  2013-11-29       Impact factor: 6.829

8.  Mechanisms of the increase in the permeability of the blood-tumor barrier obtained by combining low-frequency ultrasound irradiation with small-dose bradykinin.

Authors:  Chun-yi Xia; Zhen Zhang; Yi-xue Xue; Ping Wang; Yun-hui Liu
Journal:  J Neurooncol       Date:  2009-02-22       Impact factor: 4.130

Review 9.  Early to Long-Term Alterations of CNS Barriers After Traumatic Brain Injury: Considerations for Drug Development.

Authors:  Beatriz Rodriguez-Grande; Aleksandra Ichkova; Sighild Lemarchant; Jerome Badaut
Journal:  AAPS J       Date:  2017-09-13       Impact factor: 4.009

Review 10.  Targeting reactive nitrogen species: a promising therapeutic strategy for cerebral ischemia-reperfusion injury.

Authors:  Xing-miao Chen; Han-sen Chen; Ming-jing Xu; Jian-gang Shen
Journal:  Acta Pharmacol Sin       Date:  2012-07-30       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.